Clinical Trial Update: Effect of the Fixed Dose Combination Amlodipine/Valsartan on Central Aortic Blood Pressure in Uncontrolled Essential Hypertension With Amlodipine 5 mg [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating the effect of the fixed-dose combination of amlodipine and valsartan on central aortic blood pressure in patients with uncontrolled e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Exforge (valsartan; amlodipine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-01-21